BioOutsource to Open New Massachusetts Lab Facility - - BioPharm International

ADVERTISEMENT

BioOutsource to Open New Massachusetts Lab Facility


Scotland-based BioOutsource has announced that the company will expand its US presence, opening a new laboratory facility in Massachusetts in 2015 to support and strengthen the company’s biosimilar and biosafety service offerings. 

The company, a biologics contract testing and biosimilar characterization organization, opened its first US office in 2013 in Cambridge, Mass.  The company plans to open the new laboratory facility in early 2015 to service their North American and Latin American clients.

BioOutsource announced that the last 12 months have been an exceptional growth year for the company. The company has grown by more than 40%, with positive growth delivered across all business units.

 

Source: BioOutsource

 

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines

Click here